As Managing Director of Mobile Health, Kara leads Medidata’s efforts to support mobile-enabled clinical trials and launched mobile health as a new business unit in 2015. Prior to this, Kara served as Chief of Staff to Medidata's CEO and President as well as Medidata's VP of Strategy. She was named to the PharmaVOICE 100 in 2015 and was highlighted as a Healthcare Businesswomen's Association Rising Star that same year.
Prior to joining Medidata in 2012, Kara led teams at McKinsey & Company on strategic consulting efforts for life science and healthcare provider clients, and she also worked on acquisition of new therapies in critical care for Ikaria (now Mallinckrodt), a biotechnology company. Kara has an MBA from Harvard Business School and a BA from Yale University.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.